Reduction of dysfunction in angioplasty procedures
A composition for reducing dysfunction in angioplasty procedures comprises a selected amount of a carrier and a prostaglandin compound carried in a specified amount. The carrier does not alter the prostaglandin compound and releases the prostaglandin compound at a rate sufficient to dilate blood ves...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English French German |
Published |
08.04.1987
|
Edition | 4 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A composition for reducing dysfunction in angioplasty procedures comprises a selected amount of a carrier and a prostaglandin compound carried in a specified amount. The carrier does not alter the prostaglandin compound and releases the prostaglandin compound at a rate sufficient to dilate blood vessels to thereby produce the required efficacy. A prepackaged combination of components provides for the complete administration of the protaglandin compound before, during and after the anaioplasty procedure. |
---|---|
Bibliography: | Application Number: EP19860113836 |